SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001193125-16-745788
Filing Date
2016-10-25
Accepted
2016-10-25 07:55:33
Documents
3
Group Members
ALLERGAN HOLDCO US, INC.AUGUSTA MERGER SUB, INC.

Document Format Files

Seq Description Document Type Size
1 SC TO-T/A d231990dsctota.htm SC TO-T/A 31586
2 EX-99.(A)(1)(L) d231990dex99a1l.htm EX-99.(A)(1)(L) 13628
3 GRAPHIC g231990g67v96.jpg GRAPHIC 10048
  Complete submission text file 0001193125-16-745788.txt   55819
Mailing Address 502 WEST OFFICE CENTER DR FORT WASHINGTON PA 19034
Business Address 502 WEST OFFICE CENTER DR FORT WASHINGTON PA 19034 215-461-2000
Vitae Pharmaceuticals, Inc (Subject) CIK: 0001157602 (see all company filings)

IRS No.: 043567753 | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-88337 | Film No.: 161949290
SIC: 2834 Pharmaceutical Preparations

Mailing Address CLONSHAUGH BUSINESS AND TECHNOLOGY PARK COOLOCK, DUBLIN L2 D17 E400
Business Address CLONSHAUGH BUSINESS AND TECHNOLOGY PARK COOLOCK, DUBLIN L2 D17 E400 (216) 523-5000
Allergan plc (Filed by) CIK: 0001578845 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: SC TO-T/A
SIC: 2834 Pharmaceutical Preparations